Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

ClinicalTrials.gov ID: NCT01788527

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01788527. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.

Study identification

NCT ID: NCT01788527
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Mount Sinai Hospital, Canada; Other
Enrollment: 325 participants

Conditions and interventions

Conditions

Type 1 Diabetics Who Are Pregnant or Planning Pregnancy

Interventions

CGM Device

Device

Eligibility (public fields only)

Age range: 18 Years to 40 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 2013 (Type not available)
Primary completion: Mar 2016 (Actual)
Completion: Mar 2016 (Actual)
Last update posted: Jul 19, 2017

2013 – 2016

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Sansum Diabetes Research Institute	Santa Barbara	California	93105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01788527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 19, 2017 · Synced Nov 15, 2026